Professor Robert Clarke
Websites
-
Swedish Cardiopulmonary Bioimage Study (SCAPIS)
Scientific Advisory Board
-
Irish Longitudinal Study on Aging (TILDA)
Scientific Advisory Board
Robert Clarke
MD, MSc, DCH
Emeritus Professor of Epidemiology and Public Health Medicine
- Clinical Trial Service Unit and Epidemiological Studies Unit
Robert Clarke is an Emeritus Professor of Epidemiology and Public Health Medicine at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Honorary Consultant in Public Health Medicine and Scientific Director of the MSc in Global Health Science and Epidemiology.
His main research interests are to understand the importance of classical and novel risk factors for cardiovascular diseases. He worked on analyses of observational studies and trials in the UK and meta-analyses of international consortia of observational studies, genome-wide association studies and randomised trials for heart disease and stroke.
Over the last decade, Robert's research work has focussed on understanding the causes of stroke and heart disease (ischaemic heart disease and heart failure) in the China Kadoorie Biobank (CKB). His research work in CKB includes studies of the diagnostic accuracy, prognosis, treatment, risk prediction and evaluation of genetic and plasma biomarkers for stroke types and ischaemic heart disease and heart failure in CKB and related studies in the department and international consortia.
He was a member of the department's Strategic Oversight Committee, the International Steering Committee of CKB, Research Strategy and Management Committee of CKB and Co-chair of International Research Management Committee of CKB.
Robert qualified in clinical medicine in Ireland and worked for five years in internal medicine and four years in cardiology. After two years in clinical pharmacology at Vanderbilt University, Nashville, USA, he joined CTSU in 1991 and specialised in cardiovascular epidemiology.
Recent publications
Alcohol consumption and cause-specific mortality in older men: Whitehall-1 study of London civil servants.
Journal article
Yusuff S. et al, (2026), Eur J Epidemiol
Proteome-wide genetic analyses identify ASGR1 as a potential biomarker linking smoking with ischemic heart disease.
Journal article
Tinworth AC. et al, (2026), Nat Cardiovasc Res
Global inequalities in cardiometabolic care and achievable cardiovascular risk reduction by wealth, region, and sex: a pooled analysis of individual participant data from 76 countries.
Journal article
Gaye B. et al, (2026), Lancet Glob Health
Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease.
Journal article
Mazidi M. et al, (2026), J Am Coll Cardiol, 88, 1107 - 1120
Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease.
Journal article
Bueno Lopez C. et al, (2026), JAMA Neurol